Summit Therapeutics Revenue 2016-2019 | SMMT

Summit Therapeutics revenue from 2016 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Summit Therapeutics Annual Revenue
(Millions of US $)
2019 $57
2018 $33
2017 $3
2016 $
2015 $
2014 $
Summit Therapeutics Quarterly Revenue
(Millions of US $)
Q1 2019 $0
Q4 2019 $0
Q3 2018 $1
Q2 2018 $51
Q1 2018 $5
Q4 2018 $4
Q3 2017 $2
Q2 2017 $25
Q1 2017 $2
Q4 2017 $2
Q3 2016 $1
Q2 2016
Q1 2016
Q4 2016
Q3 2015
Q2 2015
Q1 2015
Q4 2015
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.018B $0.057B
Summit Therapeutics PLC is engaged in the discovery and development of drug to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics PLC is headquartered in Abingdon, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $58.162B 35.82
Takeda Pharmaceutical (TAK) Japan $26.185B 8.18
Astellas Pharma (ALPMY) Japan $26.156B 12.82
Grifols, S.A (GRFS) Spain $15.016B 19.16
UCB SA (UCBJF) Belgium $15.008B 0.00
Eisai (ESALY) Japan $14.405B 24.77
Merck (MKGAF) Germany $13.654B 18.63
Ionis Pharmaceuticals (IONS) United States $9.404B 20.28
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
IPSEN SA ADR (IPSEY) France $8.898B 0.00
Neurocrine Biosciences (NBIX) United States $8.643B 0.00
Sage Therapeutics (SAGE) United States $8.406B 0.00
Catalent (CTLT) United States $8.038B 32.26
Jazz Pharmaceuticals (JAZZ) Ireland $7.550B 9.94
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.754B 17.09
Tilray (TLRY) Canada $3.796B 0.00
FibroGen (FGEN) United States $3.768B 94.24
Evotec AG (EVTCY) Germany $3.545B 48.53
United Therapeutics (UTHR) United States $3.478B 0.00
Nektar Therapeutics (NKTR) United States $3.281B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.134B 11.23
Arrowhead Pharmaceuticals (ARWR) United States $2.824B 64.74
PTC Therapeutics (PTCT) United States $2.646B 0.00
Xencor (XNCR) United States $2.166B 47.24
Portola Pharmaceuticals (PTLA) United States $2.090B 0.00
Zogenix (ZGNX) United States $2.056B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.632B 59.39
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.492B 14.97
Corcept Therapeutics (CORT) United States $1.451B 19.94
Ironwood Pharmaceuticals (IRWD) United States $1.427B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.410B 23.26
Heron Therapeutics (HRTX) United States $1.381B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.206B 0.00
Aerie Pharmaceuticals (AERI) United States $1.101B 0.00
ArQule (ARQL) United States $1.067B 0.00
Radius Health (RDUS) United States $1.051B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.876B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.769B 3.43
TherapeuticsMD (TXMD) United States $0.659B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.561B 0.00
Concordia (CXRXF) Canada $0.533B 0.00
Karyopharm Therapeutics (KPTI) United States $0.531B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.531B 0.00
Akebia Therapeutics (AKBA) United States $0.527B 0.00
Endo (ENDP) Ireland $0.509B 0.90
Indivior (INVVY) United States $0.504B 1.82
Aptorum Group (APM) China $0.463B 0.00
Dermira (DERM) United States $0.446B 0.00
Dova Pharmaceuticals (DOVA) United States $0.438B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.436B 0.00
ImmunoGen (IMGN) United States $0.424B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.418B 19.03
Flexion Therapeutics (FLXN) United States $0.417B 0.00
Translate Bio (TBIO) United States $0.408B 0.00
Siga Technologies (SIGA) United States $0.405B 0.95
ChemoCentryx (CCXI) United States $0.395B 0.00
Collegium Pharmaceutical (COLL) United States $0.379B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.370B 0.00
Organogenesis Holdings (ORGO) United States $0.348B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.329B 0.00
CV Sciences (CVSI) United States $0.326B 0.00
Xeris Pharmaceuticals (XERS) United States $0.303B 0.00
CannTrust Holdings (CTST) Canada $0.300B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.298B 0.00
KalVista Pharmaceuticals (KALV) United States $0.281B 0.00
Harpoon Therapeutics (HARP) United States $0.280B 0.00
Rafael Holdings (RFL) United States $0.272B 0.00
Lannett Co Inc (LCI) United States $0.255B 2.47
La Jolla Pharmaceutical (LJPC) United States $0.252B 0.00
DURECT (DRRX) United States $0.251B 0.00
Recro Pharma (REPH) United States $0.250B 0.00
Concert Pharmaceuticals (CNCE) United States $0.249B 0.00
OptiNose (OPTN) United States $0.244B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.211B 0.00
Calithera Biosciences (CALA) United States $0.208B 0.00
Ocular Therapeutix (OCUL) United States $0.200B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.180B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.179B 0.00
Molecular Templates (MTEM) United States $0.170B 0.00
Nature's Sunshine Products (NATR) United States $0.169B 28.26
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
Redhill Biopharma (RDHL) Israel $0.145B 0.00
IMV INC (IMV) Canada $0.140B 0.00
Ardelyx (ARDX) United States $0.139B 0.00
Jounce Therapeutics (JNCE) United States $0.136B 0.00
Generex Biotechnology (GNBT) United States $0.131B 0.00
GlycoMimetics (GLYC) United States $0.126B 0.00
Majesco Entertainment (PTE) United States $0.118B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.113B 0.00
AgeX Therapeutics (AGE) United States $0.113B 0.00
MEI Pharma (MEIP) United States $0.112B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.104B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.102B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.095B 0.00
Iterum Therapeutics (ITRM) Ireland $0.095B 0.00
Mast Therapeutics (SVRA) United States $0.095B 0.00
Aquestive Therapeutics (AQST) United States $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 32.65
Cardiome Pharma (CORV) Canada $0.085B 0.00
Neos Therapeutics (NEOS) United States $0.085B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Genocea Biosciences (GNCA) United States $0.080B 0.00
Natural Alternatives (NAII) United States $0.075B 7.54
Infinity Pharmaceuticals (INFI) United States $0.075B 0.00
China SXT Pharmaceuticals (SXTC) China $0.075B 0.00
RENEURON GP (RNUGF) United Kingdom $0.075B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.072B 0.00
Otonomy (OTIC) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Nivalis Therapeutics (ALPN) United States $0.065B 0.00
Champions Oncology (CSBR) United States $0.065B 558.00
Novan (NOVN) United States $0.063B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.062B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
Capnia (SLNO) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Lipocine (LPCN) United States $0.052B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.048B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
India Globalization Capital (IGC) United States $0.041B 0.00
CTI BioPharma (CTIC) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Bio-Path Holdings (BPTH) United States $0.034B 0.00
Melinta Therapeutics (MLNT) United States $0.034B 0.00
Aclaris Therapeutics (ACRS) United States $0.033B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Biomerica (BMRA) United States $0.029B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
IsoRay (ISR) United States $0.022B 0.00
Opexa Therapeutics (ACER) United States $0.022B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Achieve Life Sciences (ACHV) United States $0.014B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.011B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.002B 0.00
Xenetic Biosciences (XBIO) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00